Detalhe da pesquisa
1.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
2.
Immunotherapy in the treatment of advanced or recurrent endometrial cancer.
Clin Adv Hematol Oncol
; 22(3): 129-139, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588272
3.
Advances in immunotherapy in cervical cancer.
Int J Gynecol Cancer
; 33(3): 403-413, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878562
4.
A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030).
Int J Gynecol Cancer
; 30(1): 139-143, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31645423
5.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
J Clin Oncol
; 41(35): 5400-5410, 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669480
6.
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study.
Cancers (Basel)
; 14(4)2022 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205662
7.
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.
Sci Rep
; 11(1): 4433, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627685
8.
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
Clin Cancer Res
; 26(16): 4206-4215, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32444417
9.
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer.
ESMO Open
; 4(2): e000444, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962959
10.
Challenges in the management of neuroendocrine cervical cancer during pregnancy: A case report.
Mol Clin Oncol
; 9(5): 519-522, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30402233